For the quarter ending 2026-03-31, SGRY had -$57,600K decrease in cash & cash equivalents over the period. -$4,300K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -2,100 | 29,000 | 25,300 | 44,900 |
| Depreciation and amortization | 38,500 | 59,900 | 39,500 | 40,300 |
| Non-cash lease expense | 11,200 | 8,700 | 9,600 | 9,900 |
| Non-cash interest expense, net | -2,300 | -3,400 | -2,200 | -1,500 |
| Equity-based compensation expense | 5,800 | -2,200 | 2,600 | 6,800 |
| Net loss on disposals, consolidations and deconsolidations | -4,300 | -11,400 | -15,600 | 3,000 |
| Loss on debt extinguishment | - | 0 | -1,300 | 0 |
| Deferred income taxes | -1,300 | 13,400 | 5,100 | -1,500 |
| Equity in earnings of unconsolidated affiliates, net of distributions received | -2,600 | 1,800 | -800 | 900 |
| Accounts receivable | -3,600 | 46,100 | 16,200 | -3,700 |
| Other operating assets and liabilities | 53,200 | -27,700 | 2,200 | 20,400 |
| Net cash provided by (used in) operating activities | 11,700 | 103,400 | 83,600 | 81,300 |
| Purchases of property and equipment | 16,000 | 12,800 | 19,800 | 23,400 |
| Payments for acquisitions, net of cash acquired | 4,200 | 109,500 | 4,600 | 4,000 |
| Proceeds from disposals of facilities and other assets | 0 | 3,600 | 0 | 38,100 |
| Purchases of equity investments | 0 | -100 | 9,600 | 0 |
| Proceeds from sales of equity investments | 900 | 1,500 | 0 | 0 |
| Other investing activities | -5,900 | 9,000 | 12,200 | 8,600 |
| Net cash provided by (used in) investing activities | -13,400 | -126,100 | -46,200 | 2,100 |
| Principal payments on long-term debt | 193,800 | 579,400 | 161,000 | 180,100 |
| Borrowings of long-term debt | 195,400 | 692,500 | 127,900 | 168,600 |
| Payments of debt issuance costs | 400 | 2,500 | 1,600 | 0 |
| Distributions to non-controlling interest holders | 58,000 | 57,200 | 52,500 | 54,000 |
| Proceeds related to ownership transactions with non-controlling interest holders | 500 | -1,900 | -600 | 1,400 |
| Other financing activities | 400 | 7,700 | 3,700 | 1,500 |
| Net cash provided by (used in) financing activities | -55,900 | 59,200 | -84,100 | -62,600 |
| Net increase (decrease) in cash and cash equivalents | -57,600 | 36,500 | -46,700 | 20,800 |
| Cash and cash equivalents at beginning of period | 239,900 | 203,400 | 250,100 | 229,300 |
| Cash and cash equivalents at end of period | 182,300 | 239,900 | 203,400 | 250,100 |
Surgery Partners, Inc. (SGRY)
Surgery Partners, Inc. (SGRY)